Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristics
This article will contribute to a comprehensive understanding of the role of triple therapy with Chinese characteristics in patients with uHCC.PMID:38325823 | DOI:10.5582/bst.2023.01326
Source: BioScience Trends - Category: Biomedical Science Authors: Jiayi Wu Junyi Wu Shuqun Li Mengchao Luo Zhenxin Zeng Yinan Li Yangkai Fu Han Li Deyi Liu Xiangye Ou Zhongtai Lin Shaoming Wei Maolin Yan Source Type: research
More News: Biomedical Science | Cancer & Oncology | Carcinoma | China Health | Hepatocellular Carcinoma | Liver Cancer | Men | Science | Toxicology